Table 4.
Compound [pmol/g] DW | Function | Haploid embryo | Zygotic embryo | Zygotic embryo after 2,4-D treatment |
---|---|---|---|---|
SA | Active | 12,593.8 ± 2454.7 a | 1503.6 ± 339.6 b | 1615.4 ± 227.6 b |
12-oxo-PDA | JA precursor | 3507.1 ± 471.0 a | 85.9 ± 2.0 b | 229.5 ± 49.4 b |
JA | JA-Ile precursor | 3782.0 ± 469.1 a | 198.3 ± 42.0 b | 335.4 ± 65.5 b |
MeJA | Inactivated | nd | nd | nd |
ABA | Active | 5979.7 ± 330.0 a | 2204.5 ± 607.8 b | 2488.6 ± 66.0 b |
ABA-glc | Inactivated | 2058.7 ± 237.4 a | 314.9 ± 79.3 b | 367.3 ± 19.3 b |
tt-ABA | Inactivated | 1020.4 ± 98.3 a | 260.2 ± 135.6 b | 388.6 ± 187.1 b |
Values are means of three replicates ± standard error. Means indicated by the same letter do not significantly differ at P < 0.05 according to one-way ANOVA and post hoc Duncan’s test.